Orgenesis Inc
NASDAQ:ORGS

Watchlist Manager
Orgenesis Inc Logo
Orgenesis Inc
NASDAQ:ORGS
Watchlist
Price: 0.16 USD 6.67% Market Closed
Market Cap: 1m USD

Operating Margin
Orgenesis Inc

-2 912.6%
Current
-1 397%
Average
-4.7%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-2 912.6%
=
Operating Profit
-26.2m
/
Revenue
899k

Operating Margin Across Competitors

No Stocks Found

Orgenesis Inc
Glance View

Market Cap
1m USD
Industry
Biotechnology

Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing and provision of technologies and services in the cell and gene therapy industry. The company is headquartered in Germantown, Maryland and currently employs 151 full-time employees. The company went IPO on 2010-07-01. The firm is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The company has developed a Point of Care Platform (POCare Platform) comprised of three enabling components, which includes a pipeline of POCare advanced therapies that are designed to be processed and produced, automated closed POCare technology systems, and a worldwide network of POCare research institutes and hospitals (POCare Network). Its products in clinical use include KYSLECEL, Tissue Genesis Icellator for Cell Assisted Lipotransfer, Cartil-S Autologous products for the treatment of osteoarthritis, and Chondroseal Autologous products for the treatment of cartilage defects.

ORGS Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-2 912.6%
=
Operating Profit
-26.2m
/
Revenue
899k
What is the Operating Margin of Orgenesis Inc?

Based on Orgenesis Inc's most recent financial statements, the company has Operating Margin of -2 912.6%.

Back to Top